The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Digital Biomarker Market Research Report 2025
Synopsis
Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.
The global Digital Biomarker market was valued at US$ 387.2 million in 2023 and is anticipated to reach US$ 22360 million by 2030, witnessing a CAGR of 82.5% during the forecast period 2024-2030.
Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.
This report aims to provide a comprehensive presentation of the global market for Digital Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Biomarker.
Report Scope
The Digital Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Digital Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Apple
Sanofi
GlaxoSmithKline
Bayer
Merck
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics
Segment by Type
Passive Digital Biomarker
Active Digital Biomarker
Segment by Application
Clinical Disease
Daily Health
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.
The global Digital Biomarker market was valued at US$ 387.2 million in 2023 and is anticipated to reach US$ 22360 million by 2030, witnessing a CAGR of 82.5% during the forecast period 2024-2030.
Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.
This report aims to provide a comprehensive presentation of the global market for Digital Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Biomarker.
Report Scope
The Digital Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Digital Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Apple
Sanofi
GlaxoSmithKline
Bayer
Merck
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics
Segment by Type
Passive Digital Biomarker
Active Digital Biomarker
Segment by Application
Clinical Disease
Daily Health
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Passive Digital Biomarker
1.2.3 Active Digital Biomarker
1.3 Market by Application
1.3.1 Global Digital Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Disease
1.3.3 Daily Health
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Biomarker Market Perspective (2019-2030)
2.2 Digital Biomarker Growth Trends by Region
2.2.1 Global Digital Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Digital Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Digital Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Digital Biomarker Market Dynamics
2.3.1 Digital Biomarker Industry Trends
2.3.2 Digital Biomarker Market Drivers
2.3.3 Digital Biomarker Market Challenges
2.3.4 Digital Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Biomarker Players by Revenue
3.1.1 Global Top Digital Biomarker Players by Revenue (2019-2024)
3.1.2 Global Digital Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Digital Biomarker Revenue
3.4 Global Digital Biomarker Market Concentration Ratio
3.4.1 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Biomarker Revenue in 2023
3.5 Digital Biomarker Key Players Head office and Area Served
3.6 Key Players Digital Biomarker Product Solution and Service
3.7 Date of Enter into Digital Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Biomarker Breakdown Data by Type
4.1 Global Digital Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Digital Biomarker Forecasted Market Size by Type (2025-2030)
5 Digital Biomarker Breakdown Data by Application
5.1 Global Digital Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Digital Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Digital Biomarker Market Size (2019-2030)
6.2 North America Digital Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Digital Biomarker Market Size by Country (2019-2024)
6.4 North America Digital Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Biomarker Market Size (2019-2030)
7.2 Europe Digital Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Digital Biomarker Market Size by Country (2019-2024)
7.4 Europe Digital Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Digital Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Digital Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Digital Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Biomarker Market Size (2019-2030)
9.2 Latin America Digital Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Digital Biomarker Market Size by Country (2019-2024)
9.4 Latin America Digital Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Digital Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Digital Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Digital Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Philips
11.1.1 Philips Company Detail
11.1.2 Philips Business Overview
11.1.3 Philips Digital Biomarker Introduction
11.1.4 Philips Revenue in Digital Biomarker Business (2019-2024)
11.1.5 Philips Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Digital Biomarker Introduction
11.2.4 Johnson & Johnson Revenue in Digital Biomarker Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Digital Biomarker Introduction
11.3.4 Pfizer Revenue in Digital Biomarker Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Detail
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Digital Biomarker Introduction
11.4.4 GE Healthcare Revenue in Digital Biomarker Business (2019-2024)
11.4.5 GE Healthcare Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Digital Biomarker Introduction
11.5.4 Novartis Revenue in Digital Biomarker Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Apple
11.6.1 Apple Company Detail
11.6.2 Apple Business Overview
11.6.3 Apple Digital Biomarker Introduction
11.6.4 Apple Revenue in Digital Biomarker Business (2019-2024)
11.6.5 Apple Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Digital Biomarker Introduction
11.7.4 Sanofi Revenue in Digital Biomarker Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Digital Biomarker Introduction
11.8.4 GlaxoSmithKline Revenue in Digital Biomarker Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Digital Biomarker Introduction
11.9.4 Bayer Revenue in Digital Biomarker Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Digital Biomarker Introduction
11.10.4 Merck Revenue in Digital Biomarker Business (2019-2024)
11.10.5 Merck Recent Development
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Detail
11.11.2 Abbott Laboratories Business Overview
11.11.3 Abbott Laboratories Digital Biomarker Introduction
11.11.4 Abbott Laboratories Revenue in Digital Biomarker Business (2019-2024)
11.11.5 Abbott Laboratories Recent Development
11.12 Asahi Kasei
11.12.1 Asahi Kasei Company Detail
11.12.2 Asahi Kasei Business Overview
11.12.3 Asahi Kasei Digital Biomarker Introduction
11.12.4 Asahi Kasei Revenue in Digital Biomarker Business (2019-2024)
11.12.5 Asahi Kasei Recent Development
11.13 Biogen
11.13.1 Biogen Company Detail
11.13.2 Biogen Business Overview
11.13.3 Biogen Digital Biomarker Introduction
11.13.4 Biogen Revenue in Digital Biomarker Business (2019-2024)
11.13.5 Biogen Recent Development
11.14 Koneksa Health
11.14.1 Koneksa Health Company Detail
11.14.2 Koneksa Health Business Overview
11.14.3 Koneksa Health Digital Biomarker Introduction
11.14.4 Koneksa Health Revenue in Digital Biomarker Business (2019-2024)
11.14.5 Koneksa Health Recent Development
11.15 Roche
11.15.1 Roche Company Detail
11.15.2 Roche Business Overview
11.15.3 Roche Digital Biomarker Introduction
11.15.4 Roche Revenue in Digital Biomarker Business (2019-2024)
11.15.5 Roche Recent Development
11.16 Huma Therapeutics
11.16.1 Huma Therapeutics Company Detail
11.16.2 Huma Therapeutics Business Overview
11.16.3 Huma Therapeutics Digital Biomarker Introduction
11.16.4 Huma Therapeutics Revenue in Digital Biomarker Business (2019-2024)
11.16.5 Huma Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
